PharmInvent

Prague, Czechia Founded: 2010 • Age: 16 yrs Acquired By Ergomed
Pharmacovigilance and regulatory services are provided to pharmaceutical firms.

About PharmInvent

PharmInvent is a Healthcare company based in Prague (Czechia) founded in 2010, and was acquired by Ergomed in November 2016. Pharmacovigilance and regulatory services are provided to pharmaceutical firms. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its legal entity is Pharminvent regulatory s.r.o.

Company details

PharmInvent offers pharmacovigilance and regulatory consulting services to Health Authorities, Pharmaceutical, Biotech and Medical Device companies. The company claims to have experts in the field of Regulatory Science, Clinical Development, and Pharmacovigilance. Pharmacovigilance services include pharmacovigilance outsourcing services (Includes Data Management, Signal Management, Risk Management, SOPs, audits, inspection support etc), establishment and maintenance of pharmacovigilance systems, and safety management in clinical trials. PharmInvent also offers regulatory and medical writing services. The company was acquired by Ergomed in December 2016. The company offers its services in Europe, US, Mexico, South America, Australia, South Africa, Russia and the CIS region.

  • Headquarters Prague, Czechia
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website pharminvent.com
  • Social LinkedIn X Facebook
  • Acquired by Ergomed (Nov 2016)
  • Legal Name Pharminvent Regulatory S.R.O.
Key Metrics

Investors in PharmInvent

PharmInvent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Clinical CRO services for oncology and rare diseases are provided.
1997ergomedplc.comGuildford, United Kingdom
Premium access

Investor details for PharmInvent

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of PharmInvent

2 dated milestones of PharmInvent across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded PharmInvent is founded.
  2. Exit Acquired by Ergomed.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pharminvent

Premium access

Complete news archive for PharmInvent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PharmInvent

PharmInvent was founded in 2010.

PharmInvent is headquartered in Prague, Czechia.

PharmInvent offers pharmacovigilance and regulatory consulting services to Health Authorities, Pharmaceutical, Biotech and Medical Device companies. The company claims to have experts in the field of Regulatory Science, Clinical Development, and Pharmacovigilance. Pharmacovigilance services include pharmacovigilance outsourcing services (Includes Data Management, Signal Management, Risk Management, SOPs, audits, inspection support etc), establishment and maintenance of pharmacovigilance systems, and safety management in clinical trials. PharmInvent also offers regulatory and medical writing services. The company was acquired by Ergomed in December 2016. The company offers its services in Europe, US, Mexico, South America, Australia, South Africa, Russia and the CIS region.

PharmInvent has 1 investor. Key investors include Ergomed.

PharmInvent operates through Pharminvent Regulatory S.R.O..

Yes. PharmInvent was acquired by Ergomed in November 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available